This inventor holds 1 USPTO granted patent. Top assignee: Nepa Gene Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Kazuo Maruyama: Innovator in Therapeutic Muscular Dystrophy Treatments
Introduction
Kazuo Maruyama is a notable inventor based in Itabashi-ku, Japan. He has made significant contributions to the field of medical technology, particularly in the treatment of muscular dystrophy. His innovative approach focuses on enhancing drug delivery systems to improve therapeutic outcomes for patients.
Latest Patents
Kazuo Maruyama holds a patent for a therapeutic drug aimed at treating Duchenne muscular dystrophy (DMD). The patent, titled "Therapeutic muscular dystrophy drug having bubble liposome loaded with morpholino as active ingredient," describes a technology that introduces a phosphorodiamidate morpholino oligomer (PMO) with enhanced cell permeability. This advancement leads to significantly improved introduction efficiency, providing a therapeutic drug that dramatically ameliorates the medical condition of DMD. The drug utilizes bubble liposomes to deliver the PMO effectively into muscle fibers, enhancing treatment efficacy through ultrasound irradiation.
Career Highlights
Maruyama's career is marked by his dedication to developing innovative solutions for complex medical challenges. His work at Nepa Gene Co., Ltd. has positioned him as a key figure in the biotechnology sector. His research focuses on creating effective treatments that address the needs of patients suffering from muscular dystrophy.
Collaborations
Kazuo Maruyama has collaborated with esteemed colleagues, including Yoichi Negishi and Yoko Takahashi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further advancing the field of therapeutic drug development.
Conclusion
Kazuo Maruyama's contributions to the treatment of muscular dystrophy through innovative drug delivery systems highlight his role as a leading inventor in the biotechnology field. His work continues to inspire advancements in medical technology, ultimately benefiting patients in need of effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile